Trial intelligence / Profile preview

Celecoxib Augmentation of Escitalopram in Bipolar Depression

NCT01479829Phase 4Completed

Sponsor
Loyola University Chicago
Start
Mar 2011
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of celecoxib oral solution in bipolar disorder (BD), sponsored by Loyola University Chicago. Started Mar 2011; status: completed.

02

Drugs

celecoxib oral solution
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT01479829.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01479829.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call